Gene · 719
Papers2,264
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,264
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PI3K-AKT activation resculpts integrin signaling to drive filamentous tau-induced proinflammatory astrogliosis. | Cell Biosci | 2023 | 37759245 | PubTator, text mining | PubMed |
| Trypanosomes and complement: more than one way to die? | Trends Parasitol | 2023 | 37758633 | PubTator, text mining | PubMed |
| Structural biology of complement receptors. | Front Immunol | 2023 | 37753090 | PubTator, text mining | PubMed |
| Identification of a cancer-associated fibroblast classifier for predicting prognosis and therapeutic response in lung squamous cell carcinoma. | Medicine (Baltimore) | 2023 | 37746966 | PubTator, text mining | PubMed |
| ScRNA-seq reveals the correlation between M2 phenotype of tumor-associated macrophages and lymph node metastasis of breast cancer. | Oncol Res | 2023 | 37744272 | PubTator, text mining | PubMed |
| Modelling and analysis of the complement system signalling pathways: roles of C3, C5a and pro-inflammatory cytokines in SARS-CoV-2 infection. | PeerJ | 2023 | 37744234 | PubTator, text mining | PubMed |
| ANXA1 is identified as a key gene associated with high risk and T cell infiltration in primary sclerosing cholangitis. | Hum Genomics | 2023 | 37735492 | PubTator, text mining | PubMed |
| Combination of an ACLY inhibitor with a GLP-1R agonist exerts additive benefits on nonalcoholic steatohepatitis and hepatic fibrosis in mice. | Cell Rep Med | 2023 | 37729871 | PubTator, text mining | PubMed |
| Biologics in steroid resistant nephrotic syndrome in childhood: review and new hypothesis-driven treatment. | Front Immunol | 2023 | 37705972 | PubTator, text mining | PubMed |
| Challenges in IgA Nephropathy Management: An Era of Complement Inhibition. | Kidney Int Rep | 2023 | 37705895 | PubTator, text mining | PubMed |
| Structural diversity of leukotriene G-protein coupled receptors. | J Biol Chem | 2023 | 37703990 | PubTator, text mining | PubMed |
| Exploring shared pathways and the shared biomarker ERRFI1 in Obstructive sleep apnoea and atherosclerosis using integrated bioinformatics analysis. | Sci Rep | 2023 | 37699925 | PubTator, text mining | PubMed |
| Differential innate immune responses of human macrophages and bronchial epithelial cells against Talaromyces marneffei. | mSphere | 2023 | 37695039 | PubTator, text mining | PubMed |
| Pathogenesis of chronic rhinosinusitis with nasal polyp and a prominent T2 endotype. | Heliyon | 2023 | 37674852 | PubTator, text mining | PubMed |
| Integrative analysis of the association between circadian rhythm and lupus nephritis. | Clin Kidney J | 2023 | 37664569 | PubTator, text mining | PubMed |
| The effect of butylphthalide on improving the neurological function of patients with acute anterior circulation cerebral infarction after mechanical thrombectomy. | Medicine (Baltimore) | 2023 | 37653792 | PubTator, text mining | PubMed |
| Exacerbated lung inflammation following secondary RSV exposure is CD4+ T cell-dependent and is not mitigated in infant BALB/c mice born to PreF-vaccinated dams. | Front Immunol | 2023 | 37646035 | PubTator, text mining | PubMed |
| Mast Cells and Basophils in IgE-Independent Anaphylaxis. | Int J Mol Sci | 2023 | 37628983 | PubTator, text mining | PubMed |
| Screening of Exosome-Derived Proteins and Their Potential as Biomarkers in Diagnostic and Prognostic for Pancreatic Cancer. | Int J Mol Sci | 2023 | 37628784 | PubTator, text mining | PubMed |
| Helicase-like transcription factor (Hltf)-deletion activates Hmgb1-Rage axis and granzyme A-mediated killing of pancreatic β cells resulting in neonatal lethality. | PLoS One | 2023 | 37624843 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/719/papers?page=13